Top

BMC Pediatrics

Published in:

Open Access 01-12-2021 | Nosocomial Infection | Research article

Epidemiology, risk factors and outcomes of bloodstream infection caused by ESKAPEEc pathogens among hospitalized children

Authors: Xiaoshan Peng, Wei Zhou, Yu Zhu, Chaomin Wan

Published in: BMC Pediatrics | Issue 1/2021

Abstract

Background

Bloodstream infection (BSI) resulting from ESKAPEEc pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp) is relevant to high mortality and economic cost. Data concerning the impact of BSI due to ESKAPEEc in pediatric population was virtually scant. Our purpose was to summarize the epidemiology, risk factors and outcomes of ESKAPEEc BSI among hospitalized children.

Methods

Inpatients diagnosed with BSI with definite etiology between January 2016 and December 2018 were enrolled retrospectively at the West China Second University Hospital. Data were systematically reviewed on patients’ clinical characteristics and laboratory findings to ascertain independent predictors, clinical features and outcomes.

Results

Of the 228 patients with BSI, 174 (76.3%) were caused by ESKAPEEc (124 MDR-ESKAPEEc). Multivariate analysis demonstrated that premature and/ or low birth weight (odds ratio [OR] = 2.981, P = 0.036), previous surgery and/or trauma (OR = 5.71, P = 0.029) and source of urinary tract infection (OR = 10.60, P = 0.004) were independently associated with ESKAPEEc BSI. The independent risk factor for MRD-ESKAPEEc BSI was nosocomial infection (OR = 3.314, P = 0.037). The overall mortality rate in patients with ESKAPEEc BSI was 14.4% (25/174), and no significant difference was ascertained in mortality between MRD-ESKAPEEc and non-MRD ESKAPEEc BSI groups (13.7% vs. 11.4%, P = 0.692). In addition, previous surgery and/or trauma, thrombocytopenia, and mechanical ventilation were significant risk factors for mortality caused by ESKAPEEc BSI.

Conclusions

More than two-thirds of BSI among hospitalized children were caused by ESKAPEEc. Previous surgery and/or trauma, thrombocytopenia and mechanical ventilation increased the risk rate for mortality in ESKAPEEc BSI. The risk factors ascertained could assist physicians to early suspect ESKAPEEc BSI and MDR ESKAPEEc BSI.

Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An. Update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12. https://doi.org/10.1086/595011.CrossRefPubMed

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development. Of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–27. https://doi.org/10.1016/S1473-3099(17)30753-3.CrossRefPubMed

Pogue JM, Kaye KS, Cohen DA, Marchaim D. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin Microbiol Infect. 2015;21(4):302–12.CrossRef

Marturano JE, Lowery TJ. ESKAPE Pathogens in Bloodstream Infections Are Associated With Higher Cost and Mortality but Can Be Predicted Using Diagnoses Upon Admission. Open Forum Infect Dis. 2019;6(12):ofz503.CrossRef

Zhen X, Lundborg CS, Sun X, Hu X, Dong H. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):137. https://doi.org/10.1186/s13756-019-0590-7.CrossRefPubMedPubMedCentral

Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One. 2017;12:e0189621. https://doi.org/10.1371/journal.pone.0189621.CrossRefPubMedPubMedCentral

Martinez-Nadal G, Puerta-Alcalde P, Gudiol C, Cardozo C, Albasanz-Puig A, Marco F, et al. Inappropriate empirical antibiotic treatment in high-risk Neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis. 2020;70(6):1068–74. https://doi.org/10.1093/cid/ciz319.CrossRefPubMed

Tacconelli E, Cataldo MA, Mutters NT, Carrara E, Bartoloni A, Raglio A, et al. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019;54(1):49–54. https://doi.org/10.1016/j.ijantimicag.2019.04.007.CrossRefPubMed

Retamar P, Portillo MM, López-Prieto MD, Rodríguez-López F, de Cueto M, García MV, et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother. 2012;56(1):472–8. https://doi.org/10.1128/AAC.00462-11.CrossRefPubMedPubMedCentral

10.

Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to treatment and mortality during mandated emergency Care for Sepsis. N Engl J Med. 2017;376(23):2235–44. https://doi.org/10.1056/NEJMoa1703058.CrossRefPubMedPubMedCentral

11.

Larru B, Gong W, Vendetti N, Sullivan KV, Localio R, Zaoutis TE, et al. Bloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities. Pediatr Infect Dis J. 2016;35(5):507–10. https://doi.org/10.1097/INF.0000000000001057.CrossRefPubMed

12.

Yang S, Xu H, Sun J, Sun S. Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012-2017. Antimicrob Resist Infect Control. 2019;8(1):61. https://doi.org/10.1186/s13756-019-0499-1.CrossRefPubMedPubMedCentral

13.

De Angelis G, Fiori B, Menchinelli G, D'Inzeo T, Liotti FM, Morandotti GA, et al. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015). Eur J Clin Microbiol Infect Dis. 2018;37(9):1627–36. https://doi.org/10.1007/s10096-018-3292-9.CrossRefPubMed

14.

Bodro M, Gudiol C, Garcia-Vidal C, Tubau F, Contra A, Boix L, et al. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients. Support Care Cancer. 2014;22(3):603–10. https://doi.org/10.1007/s00520-013-2012-3.CrossRefPubMed

15.

Bodro M, Sabé N, Tubau F, Lladó L, Baliellas C, Roca J, et al. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation. 2013;96:843–9. https://doi.org/10.1097/TP.0b013e3182a049fd.CrossRefPubMed

16.

Song SH, Li XX, Wan QQ, Ye QF. Risk factors for mortality in liver transplant recipients with ESKAPE infection. Transplant Proc. 2014;46(10):3560–3. https://doi.org/10.1016/j.transproceed.2014.08.049.CrossRefPubMed

17.

Ye QF, Zhao J, Wan QQ, Qiao BB, Zhou JD. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality. Transpl Infect Dis. 2014;16(5):767–74. https://doi.org/10.1111/tid.12278.CrossRefPubMed

18.

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228. https://doi.org/10.1007/s00134-012-2769-8.CrossRefPubMedPubMedCentral

19.

Centers for Disease Control and Prevention. CDC/ NHSN Surveillance Definitions for Specific Types of Infections. Available at: https://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current. Accessed 15 March 2020.

20.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81. https://doi.org/10.1111/j.1469-0691.2011.03570.x.CrossRefPubMed

21.

Zheng C, Zhang S, Chen Q, Zhong L, Huang T, Zhang X, et al. Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections. Antimicrob Resist Infect Control. 2020;9(1):76. https://doi.org/10.1186/s13756-020-00741-6.CrossRefPubMedPubMedCentral

22.

Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing, twenty-sixth informational supplement, M100-S26. Wayne: Clin Lab Stand Institute; 2016.

23.

Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int. 2016:2475067.

24.

Seni J, Mwakyoma AA, Mashuda F, Marando R, Ahmed M, DeVinney R, et al. Deciphering risk factors for blood stream infections, bacteria species and antimicrobial resistance profiles among children under five years of age in North-Western Tanzania: a multicentre study in a cascade of referral health care system. BMC Pediatr. 2019;19(1):32. https://doi.org/10.1186/s12887-019-1411-0.CrossRefPubMedPubMedCentral

25.

Xiao T, Yang K, Zhou Y, Zhang S, Ji J, Ying C, et al. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016. Antimicrob Resist Infect Control. 2019;8(1):144. https://doi.org/10.1186/s13756-019-0599-y.CrossRefPubMedPubMedCentral

26.

Xu A, Zheng B, Xu Y, Huang ZG, Zhong NS, Zhuo C. National epidemiology of carbapenem-resistant and extensively drug-resistant gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect. 2016;22(S1):8. https://doi.org/10.1016/j.cmi.2015.09.015.CrossRef

27.

Li Y, Li J, Hu T, Hu J, Song N, Zhang Y, et al. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China. Antimicrob Resist Infect Control. 2020;9(1):79. https://doi.org/10.1186/s13756-020-00728-3.CrossRefPubMedPubMedCentral

28.

Xiao T, Zhu Y, Zhang S, Wang Y, Shen P, Zhou Y, et al. A retrospective analysis of risk factors and outcomes of Carbapenem-resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174–83. https://doi.org/10.1093/infdis/jiz559.CrossRefPubMed

29.

Dramowski A, Madide A, Bekker A. Neonatal nosocomial bloodstream infections at a referral hospital in a middle-income country: burden, pathogens, antimicrobial resistance and mortality. Paediatr Int Child Health. 2015;35(3):265–72. https://doi.org/10.1179/2046905515Y.0000000029.CrossRefPubMed

30.

Tian L, Sun Z, Zhang Z. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. BMC Public Health. 2018;18(1):1121. https://doi.org/10.1186/s12889-018-6013-5.CrossRefPubMedPubMedCentral

31.

Choi JY, Kwak YG, Yoo H, Lee SO, Kim HB, Han SH, et al. Trends in the distribution and antimicrobial susceptibility of causative pathogens of device-associated infection in Korean intensive care units from 2006 to 2013: results from the Korean nosocomial infections surveillance system (KONIS). J Hosp Infect. 2016;92(4):363–71. https://doi.org/10.1016/j.jhin.2015.12.012.CrossRefPubMed

32.

Tsai MH, Chu SM, Hsu JF, Lien R, Huang HR, Chiang MC, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics. 2014;133(2):e322–9. https://doi.org/10.1542/peds.2013-1248.CrossRefPubMed

33.

Aizawa Y, Shoji T, Ito K, Kasai M, Sakurai H, Toyofuku E, et al. Multidrug-resistant gram-negative bacterial bloodstream infections in Children's hospitals in Japan, 2010-2017. Pediatr Infect Dis J. 2019;38(7):653–9. https://doi.org/10.1097/INF.0000000000002273.CrossRefPubMed

34.

Furuichi M, Miyairi I. Risk factors for persistent bacteremia in infants with catheter-related bloodstream infection due to coagulase-negative Staphylococcus in the neonatal intensive care unit. J Infect Chemother. 2016;22(12):785–9. https://doi.org/10.1016/j.jiac.2016.08.011.CrossRefPubMed

35.

Fica A, Bunster N, Aliaga F, Olivares F, Porte L, Braun S, et al. Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile. Braz J Infect Dis. 2014;18(2):115–23. https://doi.org/10.1016/j.bjid.2013.06.001.CrossRefPubMed

36.

Del Vecchio A. Evaluation and management of thrombocytopenic neonates in the intensive care unit. Early Hum Dev. 2014;90(Suppl 2):S51–5. https://doi.org/10.1016/S0378-3782(14)50014-X.CrossRefPubMed

37.

De Stoppelaar SF, Van 't Veer C, Van der Poll T. The role of platelets in sepsis. Thromb Haemost. 2014;112(4):666–77. https://doi.org/10.1160/TH14-02-0126.CrossRefPubMed

38.

Pigozzi L, Aron JP, Ball J, Cecconi M. Understanding platelet dysfunction in sepsis. Intensive Care Med. 2016;42(4):583–6. https://doi.org/10.1007/s00134-015-4012-x.CrossRefPubMed

Title: Epidemiology, risk factors and outcomes of bloodstream infection caused by ESKAPEEc pathogens among hospitalized children
Authors: Xiaoshan Peng
Wei Zhou
Yu Zhu
Chaomin Wan
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Nosocomial Infection
Antibiotic
Published in: BMC Pediatrics / Issue 1/2021
Electronic ISSN: 1471-2431
DOI: https://doi.org/10.1186/s12887-021-02661-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Epidemiology, risk factors and outcomes of bloodstream infection caused by ESKAPEEc pathogens among hospitalized children

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Effect of gut microbiota from Henoch-Schönlein Purpura patients on acid-sensitive ion channel 3 expression and intestinal motility in germ-free rats

Survival and predictors of mortality among severe acute malnourished under-five children admitted at Felege-Hiwot comprehensive specialized hospital, northwest, Ethiopia: a retrospective cohort study

Quality of pediatric clinical practice guidelines

Effectiveness of interventions on early neurodevelopment of preterm infants: a systematic review and meta-analysis

Long-term effectiveness of behavioural intervention in preschool children with attention deficit hyperactivity disorder in Southeast China – a randomized controlled trial

Phenylketonuria and juvenile idiopathic arthritis: a case report